| 5-FU | Fluorouracil |
| Ara-C | Cytarabine |
| AVL | Avelumab |
| AZD | AZD8055 |
| BET | Bromodomain and Extra-Terminal Domain |
| BNZ | Benralizumab |
| BTZ | Bortezomib |
| BVZ | Bevacizumab |
| CA | Chlorambucil |
| CBP | CREB-binding Protein |
| CBT | Carboplatin |
| CDK | Cyclin-dependent Kinase |
| CHAF1A | Chromatin Assembly Factor 1 Subunit A |
| CIS | Cisplatin |
| CP | Cyclophosphamide |
| CREB | cAMP Response Element-Binding Protein |
| CTX | Cetuximab |
| DCZ | Dacarbazine |
| DEX | Dexamethasone |
| DMSO | Dimethylsulfoxid |
| DNA | Deoxyribonucleic acid |
| DNMT | DNA Methyltransferase |
| DNMT3A | DNA Methyltransferase 3A |
| DNR | Daunorubicin |
| DOT1 | Disruptor of Telomeric Silencing-1 |
| DOT1L | DOT1 Like Histone Lysine Methyltransferase |
| DTX | Docetaxel |
| DXR | Doxorubicin |
| EGFR | Epidermal Growth Factor Receptor |
| EHMT2 | Euchromatic Histone-Lysine N-methyltransferase 2 |
| ER | Eribulin |
| ETO | Etoposide |
| EtOH | Ethanol |
| ETZ | Elotuzumab |
| EZH2 | Enhancer of Zeste Homolog 2 |
| FDA | Food and Drug Administration |
| FPPS | Farnesyl Pyrophosphate Synthase |
| FRET | Förster resonance energy transfer |
| FVP | Flavopiridol |
| FVT | Fulvestrant |
| GEM | Gemcitabine |
| GFP | Green Fluorescent Protein |
| HAT | Histone Acetyltransferase |
| HDAC | Histone Deacetylase |
| HDAC1 | Histone Deacetylase 1 |
| HMT | Histone Methyltransferase |
| HPH2 | Polyhomeotic Homolog 2 |
| IFO | Ifosfamide |
| IL-5 | Interleukin-5 |
| IRI | Irinotecan |
| KAT6 | Lysine(K) Acetyltransferase 6 |
| KDM | Lysine(K) Histone Demethylase |
| KDM1A | Lysine(K) Demethylase 1A |
| KDM2A | Lysine(K)-Specific Demethylase 2A |
| LY | LY294002 |
| mTOR | Mammalian Target of Rapamycin |
| mTORC1 | Mammalian Target of Rapamycin Complex 1 |
| mTORC2 | Mammalian Target of Rapamycin Complex 2 |
| NK | Natural killer |
| OLA | Olaratumab |
| OPB | Olaparib |
| OXPT | Oxaliplatin |
| PARP | Poly(ADP-ribose) Polymerase |
| PCZ | Procarbazine |
| PDGF | Platelet-derived Growth Factor |
| PDGFRα | Platelet-derived Growth Factor Receptor-α |
| PD-L1 | Programmed Death-Ligand 1 |
| PI3K | Phosphoinositide 3-Kinase |
| PMX | Pemetrexed |
| PRC1 | Protein Regulator of cytokinesis 1 |
| PRMT5 | Protein Arginine N-methyltransferase 5 |
| PTX | Paclitaxel |
| RAPA | Rapamycin |
| RING1 | Really Interesting New Gene 1 Protein |
| SETDB1 | Su(var)3-9, Enhancer-of-zeste and Trithoraxт Domain Bifurcated Histone Lysine Methyltransferase 1 |
| SLAMF7 | Signaling Lymphocytic Activation Molecule Family member 7 |
| SMARCA2 | SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 2 |
| SMARCA4 | SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 4 |
| SUV39H1 | Su(Var)3-9 Homolog 1 |
| SUV39H2 | Su(Var)3-9 Homolog 2 |
| SUV420H1 | Su(Var)4-20 Homolog 1 |
| SUV420H2 | Su(Var)4-20 Homolog 2 |
| TAM | Tamoxifen |
| TET | Ten–eleven Translocation Methylcytosine Dioxygenase |
| TMZ | Temozolomide |
| TPT | Topotecan |
| TSA | Trichostatin A |
| TSG | Tumor suppression gene |
| VCR | Vincristine |
| VEGF | Vascular Endothelial Growth Factor |
| VIS | Vismodegib |
| VPA | Valproic acid |
| WMN | Wortmannin |
| ZOL | Zoledronic acid |